Literature DB >> 28150156

Technetium 99m pyrophosphate radioisotope for diagnosis and prognosis of transthyretin cardiac amyloidosis: A call for collaboration.

Adam Castaño1,2, Mathew S Maurer3, Sabahat Bokhari4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28150156     DOI： 10.1007/s12350-017-0803-5

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  16 in total

1.  Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis.

Authors:  Claudio Rapezzi; Candida C Quarta; Pier Luigi Guidalotti; Cinzia Pettinato; Stefano Fanti; Ornella Leone; Alessandra Ferlini; Simone Longhi; Massimiliano Lorenzini; Letizia Bacchi Reggiani; Christian Gagliardi; Pamela Gallo; Caterina Villani; Fabrizio Salvi
Journal:  JACC Cardiovasc Imaging       Date:  2011-06

2.  Prognosis in Cardiac Amyloidosis by LGE: Ready for Prime Time?

Authors:  Marianna Fontana
Journal:  JACC Cardiovasc Imaging       Date:  2016-05-18

3.  Positron emission tomography (PET) utilizing Pittsburgh compound B (PIB) for detection of amyloid heart deposits in hereditary transthyretin amyloidosis (ATTR).

Authors:  Björn Pilebro; Sandra Arvidsson; Per Lindqvist; Torbjörn Sundström; Per Westermark; Gunnar Antoni; Ole Suhr; Jens Sörensen
Journal:  J Nucl Cardiol       Date:  2016-09-19       Impact factor: 5.952

4.  Standardization of 99mTechnetium pyrophosphate imaging methodology to diagnose TTR cardiac amyloidosis.

Authors:  Sabahat Bokhari; Rachelle Morgenstern; Richard Weinberg; Mona Kinkhabwala; Demetrios Panagiotou; Adam Castano; Albert DeLuca; Andrew Kontak; Zhezhen Jin; Mathew S Maurer
Journal:  J Nucl Cardiol       Date:  2016-08-31       Impact factor: 5.952

5.  Usefulness of (99m)Tc-HMDP scintigraphy for the etiologic diagnosis and prognosis of cardiac amyloidosis.

Authors:  Arnault Galat; Jean Rosso; Aziz Guellich; Axel Van Der Gucht; Stephane Rappeneau; Diane Bodez; Soulef Guendouz; Claire-Marie Tissot; Luc Hittinger; Jean-Luc Dubois-Randé; Violaine Plante-Bordeneuve; Emmanuel Itti; Michel Meignan; Thibaud Damy
Journal:  Amyloid       Date:  2015-10-14       Impact factor: 7.141

6.  Clinical implications of the technetium-99m stannous pyrophosphate myocardial scintigraphic "doughnut" pattern in patients with acute myocardial infarcts.

Authors:  R E Rude; R W Parkey; F J Bonte; S E Lewis; D Twieg; L M Buja; J T Willerson
Journal:  Circulation       Date:  1979-04       Impact factor: 29.690

7.  Multicenter Study of Planar Technetium 99m Pyrophosphate Cardiac Imaging: Predicting Survival for Patients With ATTR Cardiac Amyloidosis.

Authors:  Adam Castano; Muhammad Haq; David L Narotsky; Jeff Goldsmith; Richard L Weinberg; Rachelle Morgenstern; Ted Pozniakoff; Frederick L Ruberg; Edward J Miller; John L Berk; Angela Dispenzieri; Martha Grogan; Geoffrey Johnson; Sabahat Bokhari; Mathew S Maurer
Journal:  JAMA Cardiol       Date:  2016-11-01       Impact factor: 14.676

8.  Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy.

Authors:  Enrica Perugini; Pier Luigi Guidalotti; Fabrizio Salvi; Robin M T Cooke; Cinzia Pettinato; Letizia Riva; Ornella Leone; Mohsen Farsad; Paolo Ciliberti; Letizia Bacchi-Reggiani; Francesco Fallani; Angelo Branzi; Claudio Rapezzi
Journal:  J Am Coll Cardiol       Date:  2005-09-20       Impact factor: 24.094

9.  Technetium pyrophosphate uptake in transthyretin cardiac amyloidosis: Associations with echocardiographic disease severity and outcomes.

Authors:  Michael N Vranian; Brett W Sperry; Mazen Hanna; Rory Hachamovitch; Asad Ikram; Richard C Brunken; Wael A Jaber
Journal:  J Nucl Cardiol       Date:  2017-01-03       Impact factor: 5.952

10.  Measurement of myocardial infarct size by technetium pyrophosphate single-photon tomography.

Authors:  J R Corbett; S E Lewis; C L Wolfe; D E Jansen; M Lewis; J S Rellas; R W Parkey; R E Rude; L M Buja; J T Willerson
Journal:  Am J Cardiol       Date:  1984-12-01       Impact factor: 2.778
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.